Dr. Americus Reed II joins Somatix Advisory Board

LG Thin-Clients Feature Built-in RFID Capabilities Optimized for Use in Healthcare Facilities

Supporting its mission to help healthcare providers streamline operations and deliver exceptional patient care, LG Business Solutions USA introduced a new LG thin client...

Experien Group Acquired by Veranex

Veranex combines product development, regulatory, and market access expertise — globally and across complex and emerging markets.

Somatix announced the appointment of Dr. Americus Reed II to Somatix as an Advisory Board Member.

Dr. Americus Reed II
Dr. Americus Reed II

Somatix notes that Dr. Americus Reed II is an identity theorist and researcher in the field of marketing. He is the Whitney M. Young, Jr., Professor of Marketing at the Wharton School, University of Pennsylvania, where he has served on the faculty for two decades. Dr. Reed’s primary research and consulting areas are in brand equity and identity loyalty.

Professor Reed’s research has been published in top-tier academic journals including the Journal of Consumer Research, the Journal of Marketing Research and the Journal of Personality and Social Psychology. His teaching interests include courses in Consumer Behavior, Marketing Research, Marketing Management, Organizational Behavior and Social Psychology.

Somatix reports Professor Reed received his PhD from the University of Florida, and his MS and BA degrees from Georgia State University.

“The vision of Somatix is one I deeply identify with. When technology and data can be a force for good, to change lives, and make this world a better place, that is when I want to be involved. Somatix’s cutting edge gesture detection technology will create a water shed, game changing moment in the future of health care.”

Eran Ofir, CEO and co-founder of Somatix says, “Dr. Reed’s deep knowledge and proven experience in the areas of marketing, brand identity and consumer research will be of tremendous value to us as we commercialize our Remote Patient Monitoring platform, SafeBeing, in the US market”.

Dr. Charles Herman, President and Chief Medical Officer of Somatix, adds, “Having personally worked with Dr. Reed at Wharton, I am aware of the great value that he has added to firms across a multiplicity of industries and how valuable he will be in accelerating Somatix’s growth in the market.”



Graham Belgrave Named to the 2021 PharmaVOICE 100 List of Distinguished Leaders

At Advanced Clinical, and from previous organizations, Belgrave serves as a mentor to several colleagues, where he challenges them to think outside of the box and take risks.

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.